FDA Approved: VOCABRIA — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

FDA approved a supplemental application for VOCABRIA (cabotegravir sodium) filed by ViiV Healthcare Company under NDA 212887.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• VOCABRIA (cabotegravir sodium)

Snippet

SUPPL AP for VOCABRIA (CABOTEGRAVIR SODIUM)